Depreciation of Tevogen Bio Holdings Inc. from 31 Mar 2023 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tevogen Bio Holdings Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2023 to 31 Mar 2025.
  • Tevogen Bio Holdings Inc. Depreciation for the quarter ending 31 Mar 2025 was $40,553, a 0% increase year-over-year.
  • Tevogen Bio Holdings Inc. annual Depreciation for 2024 was $162,209, a 0.67% decline from 2023.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Tevogen Bio Holdings Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $40,553 +$1 +0% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $40,552 +$817 +2.1% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $39,735 01 Jan 2023 31 Mar 2023 10-Q 28 May 2024 2024 Q1

Tevogen Bio Holdings Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $162,209 -$1,091 -0.67% 01 Jan 2024 31 Dec 2024 10-K 02 Apr 2025 2024 FY
2023 $163,300 01 Jan 2023 31 Dec 2023 10-K 02 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.